Constellation Brands Slides 0.21% Amid Buffett’s $3.9B Stake and Analysts’ 22% Upside Outlook as $370M Volume Ranks 255th

On August 19, 2025, Constellation Brands (NYSE: STZ) closed with a 0.21% decline, trading with a volume of $0.37 billion, ranking 255th in market activity. The stock remains under scrutiny following revelations about Warren Buffett’s Q2 investment strategy, which included a $3.9 billion allocation across 12 stocks. Among these, Constellation Brands was highlighted for its strong analyst sentiment, with 16 of 25 analysts surveyed by LSEG in August recommending a "buy" or "strong buy" rating. The beverage alcohol company’s average 12-month price target suggests approximately 22% upside potential, reflecting confidence in its market position despite recent volatility.

Berkshire Hathaway’s Q2 portfolio adjustments included maintaining existing positions in Constellation Brands and expanding stakes in other sectors. Analysts noted that while UnitedHealth Group attracted the largest portion of Buffett’s investment, Constellation Brands stood out for its growth prospects. The stock’s valuation metrics, combined with its presence in Buffett’s portfolio, have drawn investor attention. However, the recent decline underscores broader market dynamics, as investors balance long-term confidence with short-term fluctuations.

A backtested trading strategy involving the top 500 stocks by daily trading volume from December 2022 to August 2025 yielded a net profit of $2,940. This approach, however, experienced a maximum drawdown of $1,960, indicating a peak-to-trough decline of 19.6% during the period. The results highlight the strategy’s volatility while affirming its overall positive returns over the timeframe.